Implants News and Research

RSS

Naltrexone for problem gamblers

According to new practice guidelines Australian doctors treating gambling addicts now can consider prescribing an anti-heroin drug, naltrexone, to help problem gamblers control their impulses. Australia has one of the world’s highest rates of problem gamblers, with about 2.1 per cent of Australians experiencing some form of gambling problem.

22 Nov 2011

FDA allows marketing of Aptus EndoStapling System to treat AAA

The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.

22 Nov 2011

Retina Implant scientific advisory board approves multi-center phase of second human clinical trial

Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company's second human clinical trial. The trial, which began in Tuebingen, Germany in 2010, will be expanded across Europe in five new sites, including two additional locations in Germany, Oxford, London and Budapest.

21 Nov 2011

MedSolutions introduces ICD Surgery Management Program

MedSolutions, a leading provider of quality-driven medical cost management services, today announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program, which uses evidence-based guidelines to ensure the clinical appropriateness of ICD and CRT-D implantation.

19 Nov 2011

Loyola surgeon first in the Chicago to implant Esteem hearing device

Lesa Merlo's hearing loss was so severe she had to read her children's lips when they talked to her. Then Dr. Sam Marzo of Loyola University Medical Center implanted a new hearing device in her middle ear. "I could hear their real laugh for the first time since they were babies," she said. "It was different, clear, pure and more beautiful than I could have ever imagined."

17 Nov 2011

UT Dallas students and faculty win three ASHA competitive awards

UT Dallas students and faculty have won three competitive awards from the American Speech Language and Hearing Association (ASHA), which will present the prizes at its annual conference this week in San Diego.

17 Nov 2011

EPO-secreting engineered vessels could reverse anemia

Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream.

15 Nov 2011

Ellipse MAGEC System wins 2011 Best New Technology in Spine Care Award

Ellipse Technologies, Inc. today announced the Company's unique MAGEC Remote Control Spinal Deformity System has been awarded the 2011 Best New Technology in Spine Care Award.

15 Nov 2011

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.

15 Nov 2011

Functional MRI illuminates brain networks activated by motion

An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead to uncontrolled twisting and turning in awkward, sometimes painful postures.

14 Nov 2011

Torax FENIX Continence Restoration System receives CE Mark

Torax Medical Inc. has received CE Mark for its FENIX Continence Restoration System, an innovative new approach to the treatment of fecal incontinence. Fecal Incontinence (FI) is the inability to control bowel movements.

14 Nov 2011

AxoGen third quarter revenues increase 42.5% to $1.1 million

AxoGen, Inc. today reported third quarter of 2011 revenues of $1.1 million, a 42.5% increase over $0.8 million reported during the third quarter of 2010.

10 Nov 2011

Kanghui third quarter total net revenue increases 26.9% to RMB80.7M

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the third quarter of 2011.

10 Nov 2011

Zimmer commences $550M public offering of senior notes

Zimmer Holdings, Inc. announced today that it has commenced a $550 million public offering of senior notes.

7 Nov 2011

$Commercial implants of ALFApump System for refractory ascites performed at Vienna General Hospital$

Commercial implants of ALFApump System for refractory ascites performed at Vienna General Hospital

Major milestone achieved in the commercial launch of new technology in the treatment of patients with refractory ascites due to liver cirrhosis.

5 Nov 2011

Smile Brands announces opening of Bright Now! Dental office in Tampa

Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Bright Now! Dental office in Tampa, FL. This new office marks the 25th office in the state of Florida.

5 Nov 2011

New UBC technology can accurately detect brain aneurysms

University of British Columbia researchers have developed new technology for monitoring brain aneurysms - an approach that is potentially less invasive and more accurate than current methods, and one that is simple enough for patients to use at home for frequent monitoring.

5 Nov 2011

Positive results from Clinuvel's US Phase II study of photoprotective drug, afamelanotide

Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.

3 Nov 2011

Medtronic initiates CoreValve System trial to treat severe aortic stenosis in Japan

Medtronic, Inc. today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve System.

From Medtronic 3 Nov 2011

Young microenvironment rejuvenates old stem cells

Old stem cells can be rejuvenated by being placed in a young microenvironment, research from The University of Texas Health Science Center San Antonio shows. This raises the possibility that patients' own stem cells may one day be rescued and banked to treat their age-related diseases.

2 Nov 2011